Last reviewed · How we verify

NCT03506555

Laparoscopic Access in General Surgery: the Closed (Veress Needle) Technique Versus the Open (Hasson) Technique

Completed NA Last updated 1 May 2018
What this trial tests

NA trial testing Laparoscopic peritoneal entry technique: Veress needle versus Hasson in Laparoscopic Surgery in 96 participants. Completed in 1 February 2016.

Timeline
1 November 2014
Primary endpoint
30 November 2015
1 February 2016

Quick facts

Lead sponsorSefako Makgatho Health Sciences University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeother
Enrollment96
Start date1 November 2014
Primary completion30 November 2015
Estimated completion1 February 2016

Drugs / interventions tested

Conditions studied

Sponsor

Sefako Makgatho Health Sciences University

Who can join

18 and older, any sex, with Laparoscopic Surgery or Laparoscopic Entry Technique. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomised controlled trial (RCT) comparing the closed (Veress needle) with the open (Hasson) laparoscopic entry technique in haemodynamically stable patients undergoing either emergency or elective surgical procedures was conducted over a 13-month period. The success rate and complications related to the technique were recorded and analysed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Laparoscopic Surgery

Currently open trials in the same condition.

Other Sefako Makgatho Health Sciences University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03506555.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing